Excalibur Management Corp Reduces Position in CVS Health Corp (CVS)

Share on StockTwits

Excalibur Management Corp decreased its stake in shares of CVS Health Corp (NYSE:CVS) by 0.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 41,592 shares of the pharmacy operator’s stock after selling 185 shares during the quarter. CVS Health comprises about 2.8% of Excalibur Management Corp’s portfolio, making the stock its 12th largest holding. Excalibur Management Corp’s holdings in CVS Health were worth $2,725,000 as of its most recent filing with the SEC.

Several other large investors also recently modified their holdings of the stock. Bell Rock Capital LLC lifted its position in CVS Health by 764.0% during the fourth quarter. Bell Rock Capital LLC now owns 432 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 382 shares during the last quarter. Daiwa SB Investments Ltd. bought a new position in CVS Health during the fourth quarter valued at $30,000. Cornerstone Advisors Inc. lifted its position in CVS Health by 71.6% during the third quarter. Cornerstone Advisors Inc. now owns 508 shares of the pharmacy operator’s stock valued at $40,000 after purchasing an additional 212 shares during the last quarter. Avestar Capital LLC lifted its position in CVS Health by 19.6% during the fourth quarter. Avestar Capital LLC now owns 951 shares of the pharmacy operator’s stock valued at $57,000 after purchasing an additional 156 shares during the last quarter. Finally, Truewealth LLC lifted its position in CVS Health by 78.6% during the fourth quarter. Truewealth LLC now owns 1,004 shares of the pharmacy operator’s stock valued at $66,000 after purchasing an additional 442 shares during the last quarter. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Several equities research analysts have recently issued reports on CVS shares. Cantor Fitzgerald started coverage on shares of CVS Health in a report on Sunday, December 2nd. They issued an “overweight” rating and a $77.84 target price for the company. ValuEngine upgraded shares of CVS Health from a “sell” rating to a “hold” rating in a report on Tuesday, November 6th. UBS Group started coverage on shares of CVS Health in a report on Thursday, January 17th. They issued a “buy” rating and a $75.00 target price for the company. Bank of America restated a “buy” rating and issued a $92.00 target price on shares of CVS Health in a report on Thursday, January 3rd. Finally, Loop Capital set a $80.00 target price on shares of CVS Health and gave the stock a “hold” rating in a report on Friday, November 9th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and thirteen have given a buy rating to the stock. The stock currently has an average rating of “Buy” and an average price target of $91.79.

In related news, CFO David M. Denton sold 25,159 shares of the firm’s stock in a transaction dated Thursday, November 29th. The shares were sold at an average price of $80.13, for a total value of $2,015,990.67. Following the transaction, the chief financial officer now owns 403 shares of the company’s stock, valued at approximately $32,292.39. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, insider Larry J. Merlo sold 166,368 shares of the firm’s stock in a transaction dated Friday, February 1st. The stock was sold at an average price of $64.51, for a total transaction of $10,732,399.68. The disclosure for this sale can be found here. Insiders sold a total of 449,763 shares of company stock valued at $30,412,036 in the last 90 days. Company insiders own 0.53% of the company’s stock.

CVS Health stock opened at $65.01 on Monday. The stock has a market capitalization of $66.23 billion, a PE ratio of 11.02, a PEG ratio of 0.88 and a beta of 1.03. The company has a debt-to-equity ratio of 1.66, a current ratio of 2.44 and a quick ratio of 1.94. CVS Health Corp has a 12-month low of $60.14 and a 12-month high of $82.15.

The company also recently announced a quarterly dividend, which was paid on Monday, February 4th. Stockholders of record on Friday, January 25th were issued a $0.50 dividend. The ex-dividend date was Thursday, January 24th. This represents a $2.00 annualized dividend and a dividend yield of 3.08%. CVS Health’s dividend payout ratio (DPR) is presently 33.90%.

ILLEGAL ACTIVITY WARNING: “Excalibur Management Corp Reduces Position in CVS Health Corp (CVS)” was first published by Week Herald and is the sole property of of Week Herald. If you are viewing this report on another site, it was stolen and reposted in violation of United States and international trademark and copyright law. The legal version of this report can be viewed at https://weekherald.com/2019/02/11/excalibur-management-corp-reduces-position-in-cvs-health-corp-cvs.html.

CVS Health Profile

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

See Also: Penny Stocks

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply